003017 Stock Overview
Operates as a chemical raw material manufacturing company in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Zhe Jiang Dayang Biotech Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥19.63 |
| 52 Week High | CN¥25.94 |
| 52 Week Low | CN¥11.91 |
| Beta | 0.58 |
| 11 Month Change | 2.72% |
| 3 Month Change | 26.97% |
| 1 Year Change | -14.20% |
| 33 Year Change | -25.66% |
| 5 Year Change | n/a |
| Change since IPO | -33.84% |
Recent News & Updates
Shareholder Returns
| 003017 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | 2.2% | -2.2% | -2.8% |
| 1Y | -14.2% | -5.7% | 2.0% |
Return vs Industry: 003017 underperformed the CN Chemicals industry which returned -3.9% over the past year.
Return vs Market: 003017 underperformed the CN Market which returned 3.2% over the past year.
Price Volatility
| 003017 volatility | |
|---|---|
| 003017 Average Weekly Movement | 5.8% |
| Chemicals Industry Average Movement | 8.0% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 003017 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 003017's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1976 | 839 | Yanggui Chen | www.dyhg.com |
Zhe Jiang Dayang Biotech Group Co., Ltd. operates as a chemical raw material manufacturing company in China and internationally. The company offers inorganic chemicals, including food additive potassium carbonate, potassium carbonate, food additive potassium bicarbonate, potassium bicarbonate, food and feed potassium chloride, agricultural grade ammonium chloride, and industrial grade ammonium chloride.
Zhe Jiang Dayang Biotech Group Co., Ltd. Fundamentals Summary
| 003017 fundamental statistics | |
|---|---|
| Market cap | CN¥1.60b |
| Earnings (TTM) | CN¥61.10m |
| Revenue (TTM) | CN¥876.50m |
26.2x
P/E Ratio1.8x
P/S RatioIs 003017 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 003017 income statement (TTM) | |
|---|---|
| Revenue | CN¥876.50m |
| Cost of Revenue | CN¥705.65m |
| Gross Profit | CN¥170.86m |
| Other Expenses | CN¥109.76m |
| Earnings | CN¥61.10m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.75 |
| Gross Margin | 19.49% |
| Net Profit Margin | 6.97% |
| Debt/Equity Ratio | 32.9% |
How did 003017 perform over the long term?
See historical performance and comparison